Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Yumi Fujimoto"'
Autor:
Yumi Fujimoto, Tomoko Yamamori Morita, Akihiro Ohashi, Hiroshi Haeno, Yumi Hakozaki, Masanori Fujii, Yukie Kashima, Susumu S. Kobayashi, Toru Mukohara
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-16 (2020)
Abstract Amplification and/or overexpression of human epidermal growth factor receptor 2 (HER2) are observed in 15–20% of breast cancers (HER2+ breast cancers), and anti-HER2 therapies have significantly improved prognosis of patients with HER2+ br
Externí odkaz:
https://doaj.org/article/910a347264864bb197702e0d7f5cb41e
Autor:
Ako Hosono, Mototsugu Shimokawa, Yoichi Naito, Takashi Hojo, Tatsuya Onishi, Takahiro Kogawa, Hirofumi Mukai, Yumi Fujimoto, Shota Kusuhara, Sumito Shingaki, Toru Mukohara, Nobuaki Matsubara, Kenichi Harano
Publikováno v:
Journal of Cancer
Background: Previous prospective studies have shown that eribulin improves the survival in patients with metastatic breast cancer (MBC). However, the optimal timing of its administration to achieve the longest extended survival and the efficacy of us
Autor:
Shusuke Akamatsu, Osamu Ogawa, Naoki Terada, Takahiro Kimura, Yumi Fujimoto, Takahiro Inoue, Nobuaki Matsubara, Takashi Kobayashi, Keiichiro Mori, Kaoru Murakami
Publikováno v:
Clinical Genitourinary Cancer. 18:e46-e54
There has been no established clinical evidence for using sequential treatment in castration-resistant prostate cancer (CRPC). Despite evident cross-resistance, androgen receptor axis-targeted agents (ARTAs), namely abiraterone (ABI) and enzalutamide
Autor:
Susumu Kobayashi, Hiroshi Haeno, Yumi Hakozaki, Yumi Fujimoto, Akihiro Ohashi, Tomoko Yamamori Morita, Masanori Fujii, Yukie Kashima, Toru Mukohara
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-16 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-16 (2020)
Amplification and/or overexpression of human epidermal growth factor receptor 2 (HER2) are observed in 15–20% of breast cancers (HER2+ breast cancers), and anti-HER2 therapies have significantly improved prognosis of patients with HER2+ breast canc
Autor:
Toshifumi Wakai, Kentaro Yamazaki, Kentaro Sawada, Kuniko Sunami, Masayuki Takeda, Shingo Matsumoto, Yoichi Naito, Kohei Shitara, Kayo Yasuda, Takayuki Yoshino, Gen Kimura, Yasuhiro Kodera, Chikashi Ishioka, Katsuya Tsuchihara, Manabu Muto, Kumiko Umemoto, Wataru Yasui, Saori Mishima, Yumi Fujimoto, Daisuke Kotani, Kazuko Sakai, Kazuto Nishio, Shigeki Umemura, Hideaki Bando, Shigehiro Koganemaru, Hideaki Takahashi, Akihito Kawazoe, Tatsuya Suzuki, Sumito Shingaki, Noboru Yamamoto, Shota Fukuoka, Hirotoshi Dosaka-Akita, Takahiro Kogawa, Hiroshi Matsumoto, Kenichi Harano, Yoshiaki Nakamura, Yasutoshi Kuboki
Publikováno v:
Cancer Science
In Japan, the social (medical) health-care system is on the way to being developed to advance personalized medicine through the implementation of cancer genomic medicine, known as "cancer clinical sequencing," which uses a next-generation sequencer.
Publikováno v:
Journal of Drug Delivery Science and Technology. 33:51-57
Solid dispersion techniques are useful for improving the dissolution of poorly water-soluble drugs. This study aimed to produce and evaluate solid dispersion tablets improving the solubility and oral bioavailability of a poorly water-soluble indometh
Publikováno v:
CHEMICAL & PHARMACEUTICAL BULLETIN. 64:1218-1221
Nifedipine (NIF) is a typical light-sensitive drug requiring protection from light during manufacture, storage, and handling of its dosage forms. The purpose of this study was to evaluate the utility of porous calcium silicate (PCS) for maintaining t
Autor:
Rafaela Alkmin da Costa, Tatiana de Assunção Zaccara, Rossana Pulcineli Vieira Francisco, Carolina Yumi Fujimoto, Cristiane de Freitas Paganotti
Publikováno v:
Revista Brasileira de Ginecologia e Obstetrícia, Vol 38, Iss 1, Pp 20-26 (2016)
Revista Brasileira de Ginecologia e Obstetrícia v.38 n.1 2016
Revista brasileira de ginecologia e obstetrícia
Federação Brasileira das Sociedades de Ginecologia e Obstetrícia (FEBRASGO)
instacron:FEBRASGO
Revista Brasileira de Ginecologia e Obstetrícia v.38 n.1 2016
Revista brasileira de ginecologia e obstetrícia
Federação Brasileira das Sociedades de Ginecologia e Obstetrícia (FEBRASGO)
instacron:FEBRASGO
Resumo Objetivo Avaliar se há correlação das dosagens de frutosamina e de hemoglobina glicosilada (HbA1c) com as frequências de desvios de glicemia capilar em gestantes com diabetes mellitus. Métodos: estudo observacional, retrospectivo, de cort
Autor:
Satoshi Fujii, Kenichi Harano, Toru Mukohara, Akihiro Ohashi, Teruhiko Yoshida, Takahiro Kogawa, Yumi Hakozaki, Yumie Hiraoka, Mineko Ushiama, Yumi Fujimoto, Susumu Kobayashi, Takeshi Kuwata
Publikováno v:
Cancer Research. 80:3531-3531
Background: BRCA2 plays an important role in DNA double-strand break repair, especially homologous recombination repair, to maintain genomic stability across generations. Germline mutations of BRCA2 increase a lifetime risk of developing breast and o
Autor:
Shota Kusuhara, Takahiro Kogawa, Toshikatsu Kawasaki, Mayu Morimoto, Nobuaki Matsubara, Kenichi Harano, Ako Hosono, Yoichi Naito, Yumi Fujimoto, Yoshiko Ishihara, Reiko Matsui, Kanako Mamishin, Toru Mukohara
Publikováno v:
Annals of Oncology. 30:vi114
Background Palbociclb is an orally available selective inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6) that is indicated for patients with hormone receptor-positive HER2-negative advanced or recurrent breast cancer with 3 weeks on/1 week off s